Company Overview: Patel Chem Specialities Ltd
Patel Chem Specialities Limited is a Gujarat-based ISO, GMP, and FDA-certified company engaged in the manufacturing of high-quality pharmaceutical excipients. Established in 2008 and converted to a public limited company in 2024, it operates with global quality certifications such as US-DMF, EP, BP, USP-NF, and more.
Core Products
The company’s product portfolio includes:
Sodium CMC (Rheollose®)
Croscarmellose Sodium (Disolwell®)
Sodium Starch Glycolate (BlowTab®)
Calcium CMC
Microcrystalline Cellulose
Pregelatinized Starch (AmyloTab™)
Sodium Monochloro Acetate
These excipients are widely used in the pharmaceutical, food, cosmetic, and personal care industries as binders, disintegrants, thickeners, and stabilizers.
Manufacturing & Exports
Manufacturing units are located in Vatva (Ahmedabad) and Talod (Himmatnagar).
Combined annual production capacity: 7,200 MT.
The company exports to 15+ countries, including the USA, Germany, UK, Japan, China, and Southeast Asia.
Financial Performance
Financial Year Revenue (₹ Cr) Net Profit (₹ Cr) EBITDA (₹ Cr) ROE ROCE
FY 2023 ₹69.75 ₹2.89 ₹5.83 – –
FY 2024 ₹82.72 ₹7.66 ₹12.02 – –
FY 2025 (Est.) ₹105.55 ₹10.57 ₹15.80 ~29.9% ~36.3%
The company has shown consistent growth in both revenue and profitability.
IPO Details (SME IPO)
IPO Opened: July 25, 2025
Closed: July 29, 2025
Listed on: August 1, 2025 (BSE SME)
IPO Size: ₹58.80 Cr
Price Band: ₹82–₹84 per share
Subscription: Over 167 times
Listing Price: Around ₹110 (Approx. 31% gain)
The IPO received a massive response and listed with a strong premium, reflecting investor confidence.
Why It’s a Valuable Company
Strong product portfolio with global demand
Reputed certifications (GMP, FDA, ISO)
Robust export base (15+ countries)
High Return Ratios (ROE ~30%, ROCE ~36%)
Consistent financial growth
Highly successful IPO with strong listing